安定細胞株製品 » Cyno Recombinant BDCA2 and FcER1G Stable Cell Line

CHO-K1/cyno BDCA2 and FcER1G Stable Cell Line

Recombinant CHO-K1 cells stably overexpress cynomolgus C-type lectin domain family 4 member C (BDCA2) and Fc epsilon receptor Ig (FcER1G) on the surface. The surface expression of BDCA2 is validated by FACS analysis.
M00594
¥1,613,997.00

Ask us a question
Overview
Product Description Recombinant CHO-K1 cells stably overexpress cynomolgus C-type lectin domain family 4 member C (BDCA2) and Fc epsilon receptor Ig (FcER1G) on the surface. The surface expression of BDCA2 is validated by FACS analysis.
Applications Binding assay or use as immunogen

Product Introduction
Expressed Gene NCBI reference sequence XM_005570023 and XM_005541196; no expressed tags
Target Protein XP_005570080 and XP_005541253
Host Cell CHO-K1
Size Two vials of frozen cells (>1×106 per vial in 1 mL)
Storage Store cells in liquid nitrogen immediately upon receipt. Thaw and recover cells within one year from the date received.
Mycoplasma Status Negative. The mycoplasma test was performed with MycoAlert™ PLUS Mycoplasma Detection Kit (Cat. No. LT07-318, Lonza).
Stability Stable through more than 16 passages without significant changes in assay performance or expression profile.

Culture Conditions
Culture Properties Adherent
Freeze Medium 95% complete growth medium, 5% (V/V) DMSO (Cat. No. D2650, Sigma)
Complete Growth Medium Ham’s F-12K (Kaighn’s) (Cat. No. 21127-022, Life Techonologies), 10% FBS (Cat. No. 10099-141, Life Techonologies)
Culture Medium Ham’s F-12K (Kaighn’s), 10% FBS, 4 μg/ml Puromycin (Cat. No. A11138-03, Life Techonologies)

Background
Gene Synonyms CLEC4C; CD303; BDCA-2 (for BDCA2); FCRG (for FcER1G)
Background BDCA-2 is a novel type II C-type lectin, which shows 50.7% sequence identity at the amino acid level to its putative murine ortholog, the murine dendritic cell–associated C-type lectin 2. In addition to its Ag-capturing function, BDCA-2 can mediate potent inhibition of induction of IFN-α/β expression in PDCs. Production of IFN-α/β in response to several different types of viruses, bacteria, CpG-DNA, dsRNA, and SLE serum is by far the most prominent feature of PDCs.

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.